Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

KILL Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

By: Business Wire

 

Agilent Technologies Inc. requests that their press release NewsItemId: 20250324197742 issued March 24, 2025 “Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval” be removed.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  205.90
+4.75 (2.36%)
AAPL  265.32
+1.44 (0.55%)
AMD  202.60
-0.48 (-0.24%)
BAC  53.35
+0.61 (1.17%)
GOOG  305.42
+2.60 (0.86%)
META  641.61
+2.32 (0.36%)
MSFT  401.24
+4.38 (1.10%)
NVDA  189.10
+4.13 (2.23%)
ORCL  157.12
+3.15 (2.04%)
TSLA  416.24
+5.61 (1.36%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.